Company

COMPANY

COMPANY

A PRECISE, PRACTICAL APPROACH TO
4D BIO-FABRICATED TRANSPLANTABLE
TISSUES AND ORGANS

Precise Bio is a regenerative medicine company that is advancing the use of bio-printed tissues and organs in patients in ophthalmology and is building a broad portfolio of R&D programs in additional medical disciplines.

The company’s commercial and R&D programs are based on its innovative 4D-bio-fabrication technology. This innovative platform comprises cell expansion, biomaterials, processes, printing technology and other critical technologies that are leading the way toward generating a robust pipeline of proprietary products with substantial clinical and commercial value.

The company’s robust technology platform allows it to advance its fabricated human cornea program concurrent with the development of other organs and tissues for use in ophthalmic indications. Moreover, the company’s technology overcomes multiple challenges in scalable, reproducible manufacturing of bio-printed tissues and organs. This positions Precise Bio for leadership in the field of regenerative medicine to address unmet needs in many indications which cannot be treated with donor tissue, or are limited by the number of available donor tissues and organs.

The company maintains offices, laboratories and production facilities in North Carolina, in the U.S. and in Shoham, Israel.

MANAGEMENT

Our team and advisory boards are made up of pioneers in the fields of tissue engineering, bio-materials, regenerative medicine and 3D printing. Read more

PARTNERSHIPS

We are joining forces with biotech and tissue engineering companies who share our mission of making transplantable organs and tissues readily available and commercially viable. Read more

MANAGEMENT

ARYEH BATT
ARYEH BATTCo-Founder & CEO
Aryeh has over two decades of executive experience leading product management and development of innovative technology products, and bringing them from R&D to marketing and sales. He served as Vice President of Business and Director of Corporate R&D at Orbotech (NASDAQ: ORBK) and CTO, Vice President of Business Development and Vice President of R&D at MangoDSP, a leading developer in signal processing. He holds a BSc in Physics and Electro-optics Engineering from the Jerusalem College of Technology.
ANTHONY ATALA,
ANTHONY ATALA,Co-Founder & CMO
Tony is the W.H. Boyce Professor and Director of Director of the Wake Forest Institute for Regenerative Medicine. He is recognized as a worldwide leader in regenerative medicine and its translation into clinical practice. He is a member of the Institute of Medicine of the National Academy of Sciences, and serves as President of the Regenerative Medicine Foundation.
SHAY SOKER,
SHAY SOKER,Co-Founder & CSO
Shay is Professor of Regenerative Medicine and Biomedical Engineering at the Wake Forest School of Medicine in the U.S. He is a world-renown expert in molecular and cellular biology, and natural biomaterials, with extensive experience in tissue and organ engineering. Many of Shay’s research projects have progressed to clinical practice and others are currently being discussed with Industry leaders.
RAN MATOKI
RAN MATOKICFO
Ran has over 20 years of executive financial experience in North America, Europe and Israel. This spans over $500M in exits, $6.7B in M&As, and $550M in equity funding for startups and large enterprises. Ran served as the CFO of Better Place Israel and prior to that as CFO and COO of Global SAP Partners and Ecosystem Division. He is CPA, and holds an Executive MBA.
LIOR SHAV
LIOR SHAVVP Business Development
Lior brings two decades of experience in healthcare investments and business development. He is a former partner in Accelmed, a leading med-tech investment firm, served as CEO of a healthcare advisory firm and was co-founder of several startups, including ETVIew (sold to Ambu) and Realview Imaging. Lior holds BSc in Industrial Engineering & Management from the Technion-Israel Institute of Technology and an MA in Political Science.
AMOS EITAN
AMOS EITANVP R&D, Precise Bio (Israel)
Amos brings over 15 years of experience in optical engineering. Prior to joining Precise Bio, he managed R&D multidisciplinary teams in various fields, ranging from optical communications to solar energy and biotech. He holds a BSc in Physics and Electro-optics Engineering from the Jerusalem College of Technology.
YISHAY HAYARDENI
YISHAY HAYARDENIR&D and Site Manager, Precise Bio (U.S.)
Yishay has over 25 years of experience in technology development and management, managing development teams in a wide range of multidisciplinary projects, including electronics, optical mechanics, software and machine vision. He holds a BSc in Electrical Engineering from the Jerusalem College of Technology.

MEDICAL ADVISORY BOARD

RICHARD L. LINDSTROM,
RICHARD L. LINDSTROM,
Dr. Lindstrom is the founder and attending surgeon at Minnesota Eye Consultants and an internationally recognized leader in corneal, cataract, refractive, glaucoma and laser surgery. He currently serves as an Adjunct Clinic Professor Emeritus at the University of Minnesota Department of Ophthalmology, and visiting professor at the UC Irvine Gavin Herbert Eye Institute. He has been at the forefront of ophthalmology’s evolutionary changes throughout his career, as a recognized researcher, teacher, inventor, writer, lecturer and highly acclaimed physician and surgeon.

Dr. Lindstrom has been awarded over 40 patents in ophthalmology and has developed a number of corneal preservation solutions, intraocular lenses and instruments that are used in clinical practices globally. He serves on many Board of Directors and is a frequent lecturer throughout the world on cornea, cataract, glaucoma, laser and refractive surgery. After graduating Magna Cum Laude from the College of Liberal Arts at the University of Minnesota, Dr. Lindstrom completed his doctorate degree in medicine in 1972.

Dr. Lindstrom has previously served as president of the International Society of Refractive Surgery from 1993 to 1994, the International Intraocular Implant Society from 2002 to 2004, the International Refractive Surgery Club from 2002 to 2004, and the American Society of Cataract and Refractive Surgery (“ASCRS”) from 2007 to 2008.

EDWARD J. HOLLAND,
EDWARD J. HOLLAND,
Dr. Holland is the Director of Cornea Services at Cincinnati Eye Institute and Professor of Ophthalmology at the University of Cincinnati. Dr. Holland has attracted worldwide referrals for medical and surgical corneal problems and for stem cell transplantation. His clinical interests include Corneal Transplantation, Cataract Surgery, and Ocular Surface Transplantation.

Dr. Holland was a former member of the Board of Trustees for the American Academy of Ophthalmology and received both the Senior Achievement Award and Life Achievement Honor Award from the AAO. He also served as the President of American Society of Cataract and Refractive Surgery. In 2008. Dr. Holland has served as the Chair of the Eye Bank Association and was the former Chair of their Medical Advisory Board. Dr. Holland has a national and international reputation for his knowledge and expertise in the field of cornea and external disease. He is frequently invited to attend lectures both nationally and internationally. Dr. Holland is the author of over 270 articles in peer review journals and has co-edited 4 editions of Cornea, the most widely read textbook on corneal disease and surgery.

He attended the Loyola-Stritch School of Medicine in Chicago and trained in Ophthalmology at the University of Minnesota.